Macleods gets FDA nod for generic Actos

02/11/2013 | Drug Store News

Macleods Pharma received FDA approval for its pioglitazone hydrochloride tablets in three strengths: 15 mg, 30 mg and 45 mg. The drug is a generic formulation of the diabetes treatment Actos, made by Takeda.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA